Publication | Closed Access

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

Breast OncologyBreast Cancer PatientsMedicineImmunologyPathologyImmune Checkpoint InhibitorImmunohistochemical ExpressionBreast CancerTrastuzumab-containing Neo-adjuvant ChemotherapyCancer TreatmentOncologyRadiation OncologyTumor Biology